[-2]pro-prostate specific antigen as an aid in prostate biopsy

Editorial

Chris Bangma. J Urol. 2012 Oct.

. 2012 Oct;188(4):1070-1.

doi: 10.1016/j.juro.2012.07.057. Epub 2012 Aug 15.

No abstract available

Comment on

Association of [-2]proPSA with biopsy reclassification during active surveillance for prostate cancer.
Tosoian JJ, Loeb S, Feng Z, Isharwal S, Landis P, Elliot DJ, Veltri R, Epstein JI, Partin AW, Carter HB, Trock B, Sokoll LJ. Tosoian JJ, et al. J Urol. 2012 Oct;188(4):1131-6. doi: 10.1016/j.juro.2012.06.009. Epub 2012 Aug 15. J Urol. 2012. PMID: 22901577 Free PMC article.
Serum index test %[-2]proPSA and Prostate Health Index are more accurate than prostate specific antigen and %fPSA in predicting a positive repeat prostate biopsy.
Lazzeri M, Briganti A, Scattoni V, Lughezzani G, Larcher A, Gadda GM, Lista G, Cestari A, Buffi N, Bini V, Freschi M, Rigatti P, Montorsi F, Guazzoni G. Lazzeri M, et al. J Urol. 2012 Oct;188(4):1137-43. doi: 10.1016/j.juro.2012.06.017. Epub 2012 Aug 15. J Urol. 2012. PMID: 22901578